Senesco Technologies Inc.
ELOX Healthcare Biotechnology
Senesco Technologies Inc.’s revenue for fiscal 2024 (year ended December 2024) was $6.4 million. In the quarter to June 2026, EPS grew 87.7% and free cash flow fell 144.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.
Follow ELOX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Jun '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
4.79 | 0.12 | 1.35 | 19.47 | 42.57 | 24.72 | 56.32 | 48.65 | 24.15 | 0.03 |
Receivables |
— | 2.72 | — | — | — | — | — | — | — | — |
Total current assets |
5.27 | 2.98 | 1.55 | 20.13 | 43.48 | 25.89 | 57.71 | 50.34 | 24.51 | 0.28 |
Property, Plant, Equpment (Net) |
— | — | 0.04 | 0.17 | 0.22 | 0.13 | 0.20 | 0.25 | 0.28 | 0.05 |
Long-term assets (Other) |
— | — | — | — | — | 0.03 | 0.11 | 0.13 | — | 5.51 |
Total non-current assets |
— | — | 0.16 | 0.99 | 1.66 | 0.58 | 1.24 | 0.38 | 0.28 | 5.56 |
Total Assets |
5.27 | 2.98 | 1.71 | 21.12 | 45.14 | 26.48 | 58.95 | 50.72 | 24.78 | 5.85 |
Notes Payable |
— | — | — | — | — | — | — | — | — | 0.41 |
Accounts Payable |
2.71 | 5.35 | 5.70 | 3.02 | 1.38 | 0.48 | 1.87 | 0.75 | 1.53 | 0.19 |
Accrued Expenses |
1.61 | 1.45 | 1.16 | 2.80 | 4.20 | 2.92 | 4.66 | 6.94 | 1.89 | 0.33 |
Current Part of Debt |
1.00 | 6.52 | 2.22 | 3.98 | — | 5.24 | 4.34 | — | — | — |
Current Part of Taxes to Pay |
— | — | — | — | — | — | 0.04 | 0.12 | — | — |
Other current liabilities |
11.82 | 13.44 | 13.44 | 12.58 | 3.72 | 0.81 | 0.40 | — | — | 1.85 |
Total current liabilities |
17.18 | 27.31 | 22.70 | 23.09 | 9.96 | 9.84 | 11.81 | 7.81 | 3.42 | 2.77 |
Long Term Debt (Total) |
— | — | 1.61 | 8.56 | 12.00 | 6.38 | 10.50 | — | — | — |
Long Term Tax Liability (Deferred) |
— | — | — | — | — | — | — | — | — | 2.20 |
Total non-current liabilities |
— | — | 1.61 | 8.69 | 12.80 | 6.41 | 10.93 | — | — | 2.20 |
Total liabilities |
17.18 | 27.31 | 24.31 | 31.78 | 22.76 | 16.25 | 22.73 | 7.81 | 3.42 | 4.97 |
Additional Paid In Capital |
288.63 | 270.22 | 268.81 | 263.71 | 262.88 | 183.25 | 174.52 | 129.83 | 60.05 | 122.40 |
Preferred Stock (Total) |
— | — | — | — | — | — | — | — | — | 0.00 |
Common Stock (Net) |
0.05 | 0.04 | 0.03 | 0.02 | 0.02 | 0.40 | 0.40 | 0.36 | 0.27 | 0.29 |
Retained Earnings |
(300.58) | (294.58) | (291.44) | (274.39) | (238.32) | (171.60) | (137.02) | (86.14) | (38.96) | (121.82) |
Treasury Stock |
— | — | — | — | 2.19 | 1.83 | 1.70 | 1.13 | — | — |
Common Equity (Total) |
(11.91) | (24.33) | (22.60) | (10.66) | 22.38 | 10.23 | 36.21 | 42.91 | 21.36 | 0.87 |
Shareholders Equity (Total) |
(11.91) | (24.33) | (22.60) | (10.66) | 22.38 | 10.23 | 36.21 | 42.91 | 21.36 | 0.87 |
Shareholders Equity and Liabilities (Total) |
5.27 | 2.98 | 1.71 | 21.12 | 45.14 | 26.48 | 58.95 | 50.72 | 24.78 | 5.85 |
Shares (Common) |
0.44 | 0.32 | 0.29 | 0.20 | 0.20 | 0.09 | 0.09 | 0.08 | 0.06 | 0.07 |
Shares (Preferred) |
— | — | — | — | — | — | — | — | — | 0.00 |
Shareholders Equity (Tangible) |
(11.91) | (24.33) | (22.60) | (10.66) | 22.38 | 10.23 | 36.21 | 42.91 | 21.36 | 0.87 |
Net Debt |
(3.79) | 6.40 | 2.48 | (6.93) | (30.57) | (13.11) | (41.48) | (48.65) | (24.15) | (0.03) |
Total Debt |
1.00 | 6.52 | 3.83 | 12.54 | 12.00 | 11.62 | 14.84 | — | — | — |